Page last updated: 2024-08-22

megestrol and goserelin

megestrol has been researched along with goserelin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bates, K; Blamey, RW; Nicholson, RI; Pearson, D; Robertson, JF1
Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Williams, MR2
Archer, SG; Barnes, D; Blamey, RW; Eliopoulos, A; Ellis, IO; Nicholson, RI; Robertson, JF; Spandidos, D1
Blamey, RW; Cannon, P; Ellis, IO; Gee, JM; Manning, DL; McClelland, RA; Nicholson, RI; Robertson, JF1

Reviews

1 review(s) available for megestrol and goserelin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for megestrol and goserelin

ArticleYear
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.
    Breast cancer research and treatment, 1994, Volume: 29, Issue:1

    Topics: Biomarkers, Tumor; Breast Neoplasms; ErbB Receptors; Female; Goserelin; Humans; Ki-67 Antigen; Megestrol; Megestrol Acetate; Menopause; Neoplasm Proteins; Nuclear Proteins; Postmenopause; Premenopause; Prognosis; Proto-Oncogene Proteins; Receptor, ErbB-2; Receptors, Estrogen; Survival Analysis; Tamoxifen

1994

Other Studies

4 other study(ies) available for megestrol and goserelin

ArticleYear
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
    British journal of cancer, 1992, Volume: 65, Issue:5

    Topics: Aged; Aging; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunoenzyme Techniques; Immunohistochemistry; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen

1992
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.
    British journal of cancer, 1990, Volume: 61, Issue:1

    Topics: Biomarkers, Tumor; Blood Sedimentation; Bone Neoplasms; Breast Neoplasms; Buserelin; C-Reactive Protein; Carcinoembryonic Antigen; Female; Ferritins; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Orosomucoid; Ovariectomy; Tamoxifen

1990
Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1990, Volume: 16, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Ferritins; Follow-Up Studies; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Remission Induction; Retrospective Studies; Tamoxifen

1990
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
    British journal of cancer, 1995, Volume: 72, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; ErbB Receptors; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Goserelin; Humans; Ki-67 Antigen; Life Tables; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Nuclear Proteins; Proportional Hazards Models; Proto-Oncogene Proteins p21(ras); Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Tumor Suppressor Protein p53

1995